Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events

NCT05224661 is registered in ClinicalTrials.gov with Center for International Blood and Marrow Transplant Research as lead sponsor.

NCT NCT05224661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05224661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events
Lead sponsor
Center for International Blood and Marrow Transplant Research
Phase
Observational
Overall status
Terminated
Start date
August 26, 2022
Completion date
December 12, 2025
Enrollment
303 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia in remission